Introduction
The cause of carcinomatous anemia can be considered relative to three major abnormal conditions: reduced hemopoietic response to anemia, red blood cell destruction, and excess loss of blood from blood vessels1-3). In the present study, we investigated the reduction of the erythropoietic function of hemopoietic tissues, together with iron metabolism, in order to clarify the initiating mechanism of carcinomatous anemia in animals bearing tumors in the oral region.
Methods
Eight-week-old male Wistar rats were used. The animals were divided into two groups: the experimental group 27 comprised cancerous rats treated with 0.5 % 9,10-dimethyl-1, 2-benzanthracene (DMBA) solution in acetone on the cheek skin three times a week for 32 weeks, and the control group comprised 19 normal rats treated with acetone alone on the cheek skin three times a week in the sam emanner as with the experimental group. In both groups, blood samples were collected via the tail vein 32 weeks after initiation of the carcinogenesis experiment. Hematologic parameters (red blood cell count, hemoglobin level and hematocrit value) were determined with the Hematology Analyzer HA/5 (Clay Adams, USA), percent reticulo- blood samples were collected at specified intervals to obtain blood counts and to determine 59Fe radioactivity in the plasma4,5). The parameters examined on the basis of 59Fe radioactivity included:
(1) the disappearance rate of 59Fe in the plasma; (2) the ratio of 59Fe radioactivity uptake by red blood cells to total 59Fe radioactivity, (i.e., the percent 59Fe utilization of red blood cells, RCU); and (3) the radioactivity per mg in the cheek skin (tumor), spleen and femur following sacrifice and autopsy at 72 hours post-injection of 59Fe-labeled Fe citrate. The tumors in the experimental group and the bone marrow in both experimental and control groups were double-stained with hematoxylin-eosin and subjected to an examination of the histopathology.
Results
Black-brown tumors approximately 10mm diameter, designated histologically as squamous cell carcinoma, appeared in all animals at the DMBA application site within 32 weeks following initiation of the experiment in the experimental group (Figs. 1, 2) .
The red blood cell counts, hemoglobin lev- Table 2 ). The disappearance rate of 59Fe in the plasma was higher in the experimental group (Fig. 3) . The percent 59Fe utilization of red blood cells (% RCU) increased relatively early (Fig. 4) 
Discussion and Conclusion
Attention has been focused on abnormal iron metabolism associated with anemia in organisms with cancer6). We, therefore, investigated whether cancer-related anemia in rats was due to a lack of available iron for hemoglobin synthesis or to a reduction of iron-transferring carriers.
In the present study, transferrin, the iron carrying factor, was increased in rats with carcinomas.
It was proposed that the decreased iron transfer via plasma (PI) in these animals was due to a lack of iron itself7). Hyperactivity of hema- Table 1 Hematological values Anemia occurred in cancerous rats, whilethe percent reticulocyte count increased. 
